tm logo
PROTRITAC
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 12 Sep 2024

Last Applicant/ Owned by

4000 Shoreline Court, Suite 250

South San Francisco

CA

94080

Serial Number

97559351 filed on 22nd Aug 2022

Registration Number

N/A

Correspondent Address

Lisa M. Dellamura

Lisa M. Dellamura Merck & Co., Inc.

Rahway, NJ 07065

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

PROTRITAC

Pharmaceutical research and development Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97559351

Mark Type

No Service Mark

Attorney Docket Number

No TM2024.013

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Sep 2024SOU EXTENSION 2 FILED
12th Sep 2024SOU EXTENSION 2 GRANTED
12th Sep 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Sep 2024SOU TEAS EXTENSION RECEIVED
03rd Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02th Apr 2024SOU EXTENSION 1 GRANTED
02th Apr 2024SOU EXTENSION 1 FILED
02th Apr 2024SOU TEAS EXTENSION RECEIVED
01st Apr 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
01st Apr 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED